Today: 2 July 2026
Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal
30 December 2025
1 min read

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

NEW YORK, December 30, 2025, 3:07 PM ET — Regular session

Shares of Almonty Industries Inc fell about 3.9% to $8.90 in afternoon trading on Tuesday after giving up an early rise, with the stock swinging between $8.90 and $9.39.

The pullback comes as investors focus on tungsten, a hard metal used in munitions, industrial tooling and electronics, at a moment when governments are pushing to secure strategic supply chains.

A CBS News report published on Monday said Chief Executive Lewis Black met U.S. officials, including at the White House, before touring Almonty’s Sangdong mine in South Korea and signing a deal tied to future tungsten supply for U.S. security needs; Black declined to discuss terms. Black told CBS the mine should be operational in the first quarter of 2026 and produce an estimated 1.2 million tons of tungsten ore a year. “It’s vital. It’s further than critical, it’s vital,” Black said. CBS News

Almonty said on Dec. 16 it delivered the first truckload of ore to Sangdong’s run-of-mine pad, a staging area where material is stockpiled before processing, calling it a step from development into active mining ahead of commercial production.

Earlier this month, Almonty closed an upsized $129.375 million underwritten share offering in the United States, led by BofA Securities, selling 20.7 million shares at $6.25 each. An underwritten offering is a stock sale where banks agree to buy shares and resell them to investors.

The company later withdrew its base shelf prospectus and a related U.S. registration statement, saying it did not intend further offerings under that framework after completing the equity raise.

A base shelf prospectus is a regulatory filing that can let a company sell shares or other securities over a set period without preparing a fresh prospectus for each transaction.

ALM closed at $9.26 on Monday and is up about 7% from its Dec. 18 close of $8.35, according to Stock Analysis data.

Investors are now watching for updates on commissioning and ramp-up at Sangdong, and for any disclosures that clarify the scale and duration of U.S.-linked supply commitments.

The next decisive catalyst is execution: moving from first ore and test runs to steady output often exposes bottlenecks, cost pressure and timeline risk that can drive outsized moves in smaller mining stocks.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • OpenAI Said to Push IPO to 2027, Giving Anthropic a Shot at First Public Listing
    July 2, 2026, 5:36 PM EDT. OpenAI may delay its IPO until 2027, shifting how investors look at public AI companies. That move could let Anthropic, last valued at $965 billion, hit the market first and set the early benchmarks for rivals. Experts say whichever company debuts first is likely to shape what investors expect from the rest. Anthropic going public could help with hiring, give it stock for acquisitions, and build customer trust with more transparent numbers. OpenAI, meanwhile, could take notes on any problems Anthropic runs into by waiting. If both companies hold off on listing, questions about AI stock values and business strength may grow, potentially delaying other AI IPOs, too. Timing here is key to how investors will approach the sector.
HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Previous Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Eli Lilly stock dips after hours as Jardiance, Mounjaro price-cut headlines land into 2026
Next Story

Eli Lilly stock dips after hours as Jardiance, Mounjaro price-cut headlines land into 2026

Go toTop